2026-525619-15-00招募中1 期
A study to assess the safety, and blood levels of CTX-187 after single and repeated intravenous doses in healthy volunteers and patients with bacterial infection
Centauri Therapeutics Limited1 个研究点 分布在 1 个国家目标入组 68 人开始时间: 2026年5月19日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 68
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Dr. Debra Barker
Scientific
Centauri Therapeutics Limited
研究点 (1)
Loading locations...
相似试验
招募中
2 期
A study to evaluate the safety and efficacy of the tumor-targeting human antibody-cytokine fusion protein L19TNF plus lomustine in patients with glioblastoma at first progressionGlioblastoma2022-501822-39-00Philogen S.p.A.113
招募中
1 期
A study to evaluate the safety and tolerability of single ascending doses of AGMB-101 in healthy participants (Part A) and patients with liver cirrhosis (Part B).liver cirrhosis2024-515074-26-00AgomAb Therapeutics64
招募中
1 期
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid MalignanciesParticipants with Advanced Solid Malignancies2024-511453-22-00Kumquat Biosciences Inc.112
招募中
1 期
To evaluate the pharmacokinetics and safety of nolasibannot applicable (submitted trial is a pharmacokinetic study in healthy subjects)2025-523706-32-00ReproNovo ApS28
招募中
不适用
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease (J2A-MC-GZPR)Peripheral Arterial DiseasejRCT20312505701,205